Discovery, Structure-Activity Relationship, and Mechanistic Studies of 1-((3R,4S)-3-((Dimethylamino)methyl)-4-hydroxy-4-(3-methoxyphenyl)piperidin-1-yl)-2-(2,4,5-trifluorophenyl)ethan-1-one as a Novel Potent Analgesic | |
Huang, Huoming1; Li, Xueping2,3; Xie, Peng1; Li, Xinwei1; Xu, XueJun2; Qian, Yuanyuan1; Yuan, Congmin1; Meng, Xiangguo4; Chai, JingRui2; Chen, Jing2 | |
刊名 | JOURNAL OF MEDICINAL CHEMISTRY |
2021-07-08 | |
卷号 | 64期号:13页码:9458-9483 |
ISSN号 | 0022-2623 |
DOI | 10.1021/acs.jmedchem.1c00722 |
通讯作者 | Li, Wei(wei-li@fudan.edu.cn) ; Wang, YuJun(yjwang@mail.simm.ac.cn) ; Fu, Wei(wfu@fudan.edu.cn) |
英文摘要 | Management of moderate to severe pain relies heavily on opioid analgesics such as morphine, oxycodone, and fentanyl in clinics. However, their prolonged use was associated with undesirable side effects. Many new strategies to reduce side effects have been proposed, but not without disadvantages. Using a hot plate model as a phenotypic screening method, our studies identified (3R,4S)-9d with a new scaffold as a potent analgesic with ED50 values of 0.54 mg/kg and 0.021 mg/kg in hot plate and antiwrithing models, respectively. Mechanistic studies showed that it elicited its analgesic effect via the active metabolite (3R,4S)-10a. The mechanism of (3R,4S)-10a-induced activation of the mu opioid receptor (MOR) was proposed by means of molecular dynamics (MD) simulation. |
资助项目 | National Natural Science Foundation of China[81773635] ; National Natural Science Foundation of China[82073765] ; Shanghai Science and Technology Development Funds[19431900500] ; Shanghai Science and Technology Development Funds[20S11902400] ; Youth Innovation Promotion Association of the Chinese Academy of Sciences[2017334] |
WOS关键词 | MU-OPIOID-RECEPTOR ; ACID SUBSTITUTED DERIVATIVES ; MOLECULAR-MECHANISMS ; MORPHINE-TOLERANCE ; MICE LACKING ; TRAMADOL ; AGONIST ; EFFICACY ; INSIGHTS ; LIGAND |
WOS研究方向 | Pharmacology & Pharmacy |
语种 | 英语 |
出版者 | AMER CHEMICAL SOC |
WOS记录号 | WOS:000672729800036 |
内容类型 | 期刊论文 |
源URL | [http://119.78.100.183/handle/2S10ELR8/296949] |
专题 | 中国科学院上海药物研究所 |
通讯作者 | Li, Wei; Wang, YuJun; Fu, Wei |
作者单位 | 1.Fudan Univ, Sch Pharm, Dept Med Chem, Shanghai 201203, Peoples R China 2.Chinese Acad Sci, Shanghai Inst Mat Med, Key Lab Receptor Res, Shanghai 201203, Peoples R China 3.Univ Chinese Acad Sci, Beijing 100049, Peoples R China 4.Shanghai Univ Med & Hlth Sci, Sch Pharm, Shanghai 201318, Peoples R China |
推荐引用方式 GB/T 7714 | Huang, Huoming,Li, Xueping,Xie, Peng,et al. Discovery, Structure-Activity Relationship, and Mechanistic Studies of 1-((3R,4S)-3-((Dimethylamino)methyl)-4-hydroxy-4-(3-methoxyphenyl)piperidin-1-yl)-2-(2,4,5-trifluorophenyl)ethan-1-one as a Novel Potent Analgesic[J]. JOURNAL OF MEDICINAL CHEMISTRY,2021,64(13):9458-9483. |
APA | Huang, Huoming.,Li, Xueping.,Xie, Peng.,Li, Xinwei.,Xu, XueJun.,...&Liu, Jinggen.(2021).Discovery, Structure-Activity Relationship, and Mechanistic Studies of 1-((3R,4S)-3-((Dimethylamino)methyl)-4-hydroxy-4-(3-methoxyphenyl)piperidin-1-yl)-2-(2,4,5-trifluorophenyl)ethan-1-one as a Novel Potent Analgesic.JOURNAL OF MEDICINAL CHEMISTRY,64(13),9458-9483. |
MLA | Huang, Huoming,et al."Discovery, Structure-Activity Relationship, and Mechanistic Studies of 1-((3R,4S)-3-((Dimethylamino)methyl)-4-hydroxy-4-(3-methoxyphenyl)piperidin-1-yl)-2-(2,4,5-trifluorophenyl)ethan-1-one as a Novel Potent Analgesic".JOURNAL OF MEDICINAL CHEMISTRY 64.13(2021):9458-9483. |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论